Key Findings From 2025 Clinical Trials The year 2025 has already delivered several groundbreaking trials that provide new evidence for cardiovascular outcomes in diabetes: 1
Literature indicates that nearly one-third of psychiatric and psychogeriatric hospital admissions exhibit low red cell folate levels or decreased serum folate levels, even in the absence of anemia or macrocytosis (20, 21)
The other avenue of research is more clinical trials with GLP-1 RAs plus psoriasis medicines. Additionally, GLP-1 RA therapy is being explored for use in other dermatologic conditions, including hidradenitis suppurativa, acanthosis nigricans, chronic wounds and ulcers, weight-loss-related lipoatrophy, and skin laxity
Jay Campbell discusses on the podcast how, combined with another peptide like TB 500, BPC-157 is effective not only in reducing inflammation but also in accelerating the healing process of tissues 1
The medication alone is not how people are finding weight loss success
It's best to start with a lower dose and adjust as needed